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Acute Cervical 
Lymphadenitis 
Caused by 
Mycobacterium 
ﬂ  orentinum
To the Editor: The incidence 
of nontuberculous mycobacterium 
(NTM) lymphadenitis appears to be 
rising, likely because of improved diag-
nostic techniques. Mycobacterium avi-
um-intracellulare is the most common 
etiologic agent of NTM lymphadenitis 
in children (1,2). Newer diagnostic 
methods, including DNA sequencing, 
have identiﬁ  ed cervical adenitis sec-
ondary to other slow-growing species 
(M. lentiﬂ  avum, M. interjectum, and, 
most recently M. ﬂ  orentinum in 2005) 
(3–6). We report a case of acute cer-
vical lymphadenitis caused by M. ﬂ  o-
rentinum in a child and brieﬂ  y describe 
4 other patients, both children and 
adults, with positive culture growth. 
These results suggest that M. ﬂ  orenti-
num infection is more widespread than 
previously appreciated.
A previously healthy girl, 3 years 
of age, came to our outpatient clinic 
with 2 months of bilateral cervical 
lymph node enlargement preceded by 
low-grade fevers for a few days. She 
had previously received clindamycin 
for 10 day without improvement. A 
tuberculin skin test showed 10 mm of 
induration, and results of a chest ra-
diograph were negative. Both parents 
were from El Salvador, but the child 
was born in the United States and had 
never traveled abroad.
Her examination showed enlarged 
left (6 × 4 cm) and right (4 × 3 cm) 
posterior, cervical lymph nodes, which 
were indurated, erythematous, and 
ﬂ  uctuant. Computed tomography scan 
of the neck showed multiple, bilateral, 
necrotic lymph nodes in the posterior 
cervical triangle, more notable on the 
right, with retropharyngeal abscesses 
(Figure).
The patient was admitted to the 
hospital because of concerns about 
airway obstruction. Laboratory ﬁ  nd-
ings included leukocyte count of 9.8 
× 103 cells/μL (40% neutrophils), in-
creased thrombocytes (523 × 103 cells/
μL), and a routine, negative blood cul-
ture for bacterial growth. She had el-
evated alanine aminotransferase (822 
U/L), aspartate aminotransferase (482 
U/L), and lactate dehydrogenase (387 
U/L) levels. Computed tomography 
scan of the abdomen showed no ab-
scesses. She was given intravenous 
vancomycin.
The following day she underwent 
neck exploration, excisional left lymph 
node biopsy, and drainage of her ret-
ropharynx. Retropharyngeal cultures 
grew methicillin-resistant Staphylo-
coccus epidermidis and Streptococcus 
mitis. Lymph node histopathologic 
analysis showed noncaseating granu-
lomas with no malignancy. Results of 
tests with special stains for acid-fast 
bacilli and fungi were negative. She 
was discharged home after receiving 
oral linezolid for 10 days to complete 
14 days of antimicrobial drug therapy. 
Her liver function test results had im-
proved at the time of discharge.
The excised lymph node and neck 
abscess grew atypical mycobacteria, 
which were initially isolated by us-
ing an automated broth culture system 
(MGIT; Becton Dickinson, Sparks, 
MD, USA) after 4 weeks of incuba-
tion. Cultures were negative for M. 
avium complex by DNA hybridiza-
tion, nonpigmented, and positive for 
nitrate reductase and inactivation of 
catalase at 68°C.
At the time of follow-up, the pa-
tient’s neck swelling had only slightly 
decreased, which resulted in complete 
surgical excision of bilaterally infect-
ed lymph nodes 3 weeks later with 
subsequent improvement. Repeat my-
cobacterial cultures were negative. No 
relapse occurred within 12 months of 
observation following surgery.
The isolate was identiﬁ  ed as M. 
ﬂ  orentinum at Associated Regional 
and University Pathologists Labora-
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Figure. Computed tomography scan of the neck of a 3-year-old girl, showing right lateral 
retropharyngeal abscess (white arrows) and enlarged bilateral posterior cervical lymph 
nodes with low attenuation of a right cervical lymph node (black arrow), consistent with 
atypical mycobacterium adenitis.LETTERS
tories (Salt Lake City, UT, USA) on 
the basis of sequencing of the ﬁ  rst 500 
bp of the 16S rRNA gene. The patient 
isolate exhibited 484/484 nt identities 
with the type strain of M. ﬂ  orentinum. 
The isolate was susceptible to amika-
cin and clarithromycin with MICs of 
0.5 μg/mL but was resistant to cipro-
ﬂ   oxacin (MIC 8 μg/mL), according 
to Clinical and Laboratory Standards 
Institute guidelines (www.clsi.org). 
Other drugs tested (with correspond-
ing MICs) included ethambutol (4 μg/
mL), gatiﬂ  oxacin  (2  μg/mL), moxi-
ﬂ  oxacin (1 μg/mL), rifampin (0.12 μg/
mL), and streptomycin (0.5 μg/mL). 
No current Clinical and Laboratory 
Standards Institute interpretations are 
available for these agents.
Four additional cases of M. ﬂ  o-
rentinum infection have been identiﬁ  ed 
at Associated Regional and University 
Pathologists Laboratories since 2006 
(after Institutional Review Board ap-
proval): a 76-year-old man (bronchial 
aspirate), a 47-year-old man (sputum), 
a 5-year-old girl (neck lymph node), 
and a 46-year-old man (unspeciﬁ  ed 
source). Two of these cases were sub-
mitted from New York, 1 from Or-
egon, and 1 from Virginia.
M. ﬂ  orentinum is a recently de-
scribed, slow-growing, nonpigmented 
mycobacterium. In 2005, Tortoli et al. 
described 8 strains obtained over 11 
years from the sputum of patients with 
various pulmonary disorders and, in 1 
case, from the lymph node of a 6-year-
old girl (6). Seven of the 8 patients 
were hospitalized in Italy.
Atypical mycobacterium lymph-
adenitis generally shows unilateral 
lymph node involvement; however, 
the patient reported here had bilateral 
lymphadenitis complicated by retro-
pharyngeal abscesses. Although dis-
seminated NTM infection can lead 
to liver abnormalities, this patient 
had no risk factors for dissemination 
such as immunosuppression. Recom-
mended treatment of atypical NTM 
lymphadenitis in children is complete 
surgical excision (5,7), although some 
studies have suggested antimicrobial 
drugs (1,7,8) or observation alone (9). 
M. ﬂ  orentinum exhibits resistance to 
several antimycobacterial drugs (6); 
therefore, surgical excision may still 
be the preferred treatment for this in-
fection. Because the patient reported 
here had complete surgical excision 
and no recurrence, she did not require 
further antimicrobial drugs.
Cervical lymphadenitis in chil-
dren is thought to result from inges-
tion of environmental mycobacteria 
(10). Although many NTM species are 
speciﬁ  c to particular geographic loca-
tions, our data suggest that M. ﬂ  orenti-
num is found in diverse locations in 
the United States. This organism ap-
pears to have a predilection for lymph 
nodes and lung tissue, similar to other 
NTM species.
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